Kentucky · 2026 Regular Session · Resolution
SR 201: A RESOLUTION encouraging Kentucky policymakers to study, develop, and implement economic development policies to incentivize biopharmaceutical investment and innovation in Kentucky.
Passed one chamber Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
SR 201 is a resolution introduced in the Kentucky Senate on March 26, 2026. According to its official title, it concerns: A RESOLUTION encouraging Kentucky policymakers to study, develop, and implement economic development policies to incentivize biopharmaceutical investment and innovation in Kentucky. Primary sponsor: Shelley Frommeyer (Republican), Robert Stivers (Republican). Most recent recorded action (April 1, 2026): adopted by voice vote.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Official summary
Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.
Encourage Kentucky policymakers to study, develop, and implement economic development policies to incentivize biopharmaceutical investment and innovation in the Commonwealth.
Sponsors
Sponsors by party (alphabetical): Republican 2
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Shelley Frommeyer | Primary sponsor | Republican | Senate | 24 |
| Robert Stivers | Primary sponsor | Republican | Senate | 25 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- adopted by voice vote
- to Senate Floor
- to Committee on Committees (S)
- introduced in Senate